You are currently viewing a new version of our website. To view the old version click .

Biomedicines, Volume 9, Issue 10

October 2021 - 215 articles

Cover Story: Plague is an ancient disease that remains relevant today. Plague is caused by Yersinia pestis, a vector-borne bacterium that is responsible for millions of deaths throughout history. Plague manifests as three distinct clinical forms. Bubonic plague is the most common form of the disease and causes enlarged and painful lymph nodes called buboes. Septicemic plague occurs if bacteria enter the bloodstream directly or as a secondary consequence. Pneumonic plague is a severe lung infection initiated upon inhaling bacteria. The inhalational form of the disease can also be spread person-to-person after exposure to an infected individual. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (215)

  • Review
  • Open Access
59 Citations
5,833 Views
28 Pages

Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu

  • Md Habban Akhter,
  • Habibullah Khalilullah,
  • Manish Gupta,
  • Mohamed A. Alfaleh,
  • Nabil A. Alhakamy,
  • Yassine Riadi and
  • Shadab Md

Nanoparticles (NPs) in contact with a biological medium are rapidly comprehended by a number of protein molecules resulting in the formation of an NP–protein complex called protein corona (PC). The cell sees the protein-coated NPs as the synthetic id...

  • Review
  • Open Access
20 Citations
5,187 Views
12 Pages

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors

  • Andrea Matucci,
  • Emanuele Vivarelli,
  • Francesca Nencini,
  • Enrico Maggi and
  • Alessandra Vultaggio

Bronchial asthma and its frequent comorbidity chronic rhinosinusitis (CRS), are characterized by an inflammatory process at lower and upper respiratory tract, with a variability in terms of clinical presentations (phenotypes) and distinct underpin pa...

  • Article
  • Open Access
15 Citations
3,405 Views
15 Pages

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy

  • Ahlem Jebali,
  • Maxime Battistella,
  • Céleste Lebbé and
  • Nicolas Dumaz

The network defined by phosphatidylinositol-3-kinase (PI3K), AKT, and mammalian target of rapamycin (mTOR) plays a major role in melanoma oncogenesis and has been implicated in BRAF inhibitor resistance. The central role of RICTOR (rapamycin-insensit...

  • Article
  • Open Access
14 Citations
3,809 Views
15 Pages

Styrene Maleic Acid Copolymer-Based Micellar Formation of Temoporfin (SMA@ mTHPC) Behaves as A Nanoprobe for Tumor-Targeted Photodynamic Therapy with A Superior Safety

  • Jun Fang,
  • Shanghui Gao,
  • Rayhanul Islam,
  • Hinata Nema,
  • Rina Yanagibashi,
  • Niho Yoneda,
  • Natsumi Watanabe,
  • Yuki Yasuda,
  • Naoki Nuita and
  • Jian-Rong Zhou
  • + 1 author

Tumor-targeted photodynamic therapy (PDT) using polymeric photosensitizers is a promising anticancer therapeutic strategy. Previously, we developed several polymeric nanoprobes for PDT using different polymers and PDT agents. In the study, we synthes...

  • Review
  • Open Access
17 Citations
5,022 Views
42 Pages

Footprints of microRNAs in Cancer Biology

  • Yaashini Rajasegaran,
  • Adam Azlan,
  • Aliaa Arina Rosli,
  • Mot Yee Yik,
  • Khor Kang Zi,
  • Narazah Mohd Yusoff and
  • Emmanuel Jairaj Moses

MicroRNAs (miRNAs) are short non-coding RNAs involved in post-transcriptional gene regulation. Over the past years, various studies have demonstrated the role of aberrant miRNA expression in the onset of cancer. The mechanisms by which miRNA exerts i...

  • Article
  • Open Access
15 Citations
2,770 Views
12 Pages

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

  • Bernhard Schlevogt,
  • Klaus H. W. Boeker,
  • Stefan Mauss,
  • Hartwig Klinker,
  • Renate Heyne,
  • Ralph Link,
  • Karl-Georg Simon,
  • Christoph Sarrazin,
  • Yvonne Serfert and
  • Michael P. Manns
  • + 1 author

Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well define...

  • Article
  • Open Access
7 Citations
3,511 Views
13 Pages

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients

  • Alexander Jordan,
  • Pradeesh Sivapalan,
  • Josefin Eklöf,
  • Jakob B. Vestergaard,
  • Howraman Meteran,
  • Mohamad Isam Saeed,
  • Tor Biering-Sørensen,
  • Anders Løkke,
  • Niels Seersholm and
  • Jens Ulrik Stæhr Jensen

Psychiatric side effects are well known from treatment with systemic corticosteroids. It is, however, unclear whether inhaled corticosteroids (ICS) have psychiatric side effects in patients with COPD. We conducted a nationwide cohort study in all Dan...

  • Review
  • Open Access
24 Citations
6,140 Views
17 Pages

The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments

  • Phumelele Yvonne Siphepho,
  • Yi-Ting Liu,
  • Ciniso Sylvester Shabangu,
  • Jee-Fu Huang,
  • Chung-Feng Huang,
  • Ming-Lun Yeh,
  • Ming-Lung Yu and
  • Shu-Chi Wang

Metabolic derangement is characteristic in patients with hepatitis C virus (HCV) infection. Aside from established liver injury, various extrahepatic metabolic disorders impact the natural history of the disease, clinical outcomes, and the efficacy o...

  • Article
  • Open Access
5 Citations
3,535 Views
13 Pages

Tetradecyl 2,3-dihydroxybenzoate (ABG-001) is a lead compound derived from gentisides with a remarkable neuritogenic activity. However, the target of ABG-001 is yet to be defined to date. In this study, the potential target of ABG-001 was investigate...

  • Review
  • Open Access
21 Citations
5,607 Views
12 Pages

Immune-checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death-1 (PD-1), and programmed cell death-1-ligand 1 (PD-L1) have become new treatment options for various malignancies. ICIs bind to immune-chec...

of 22

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059